<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The efficacy and safety of repeated administration of infliximab was evaluated in five patients (two men, three women) with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome accompanied by severe uveoretinitis </plain></SENT>
<SENT sid="1" pm="."><plain>Ocular and extra <z:hpo ids='HP_0100533'>ocular inflammation</z:hpo> was suppressed in <z:hpo ids='HP_0000001'>all</z:hpo> patients during the observation period without any serious adverse reactions </plain></SENT>
<SENT sid="2" pm="."><plain>The results in these patients suggests that TNF-á blockade is effective in patients with severe ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet syndrome </plain></SENT>
</text></document>